ACP
NDRM
Acuta Capital Partners’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-72,866
| Closed | -$2.18M | – | 77 |
|
|
2017
Q2 | $2.18M | Sell |
72,866
-377,134
| -84% | -$11.3M | 0.61% | 25 |
|
|
2017
Q1 | $11.9M | Sell |
450,000
-215,944
| -32% | -$5.73M | 2.83% | 8 |
|
|
2016
Q4 | $14.8M | Buy |
665,944
+202,988
| +44% | +$4.51M | 5.5% | 5 |
|
|
2016
Q3 | $8.56M | Sell |
462,956
-171,044
| -27% | -$3.16M | 3.21% | 7 |
|
|
2016
Q2 | $10.3M | Sell |
634,000
-192,799
| -23% | -$3.13M | 4.95% | 4 |
|
|
2016
Q1 | $11.7M | Buy |
826,799
+349,499
| +73% | +$4.93M | 6.53% | 5 |
|
|
2015
Q4 | $8.14M | Sell |
477,300
-19,330
| -4% | -$330K | 3.89% | 7 |
|
|
2015
Q3 | $10.3M | Buy |
496,630
+196,630
| +66% | +$4.06M | 5.94% | 3 |
|
|
2015
Q2 | $4.61M | Buy |
300,000
+196,833
| +191% | +$3.02M | 2.85% | 8 |
|
|
2015
Q1 | $1.39M | Buy |
+103,167
| New | +$1.39M | 1.17% | 24 |
|